Streptozotocin (STZ)-Induced Diabetic Model

The streptozotocin diabetes model is widely utilized in research to study the pathophysiology and treatment of diabetes. Streptozotocin (STZ) is a naturally occurring chemical that is particularly toxic to the insulin-producing beta cells in the pancreas. By administering STZ to laboratory animals, researchers can induce a state of diabetes that closely mimics the human condition. This model is instrumental in testing new diabetes treatments and understanding the disease’s progression, allowing scientists to explore innovative therapies and potential cures for diabetes.